Pharmacology publications :
779
Collection home page

Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Issue Date in Descending order): 1 to 20 of 779
PreviewIssue DateTitleAuthor(s)
2017Advances in drug metabolism and pharmacogenetics research in AustraliaMackenzie, P.; Somogyi, A.; Miners, J.
2016Diversion and injection of buprenorphine-naloxone film two years post-introduction in AustraliaLarance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.
2015Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioidsPeacock, A.; Bruno, R.; Cama, E.; Kihas, I.; Larance, B.; Lintzeris, N.; Hordern, A.; White, N.; Ali, R.; Degenhardt, L.
2015Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulationPeacock, A.; Degenhardt, L.; Hordern, A.; Larance, B.; Cama, E.; White, N.; Kihas, I.; Bruno, R.
2015The characteristics of a cohort who tamper with prescribed and diverted opioid medicationsLarance, B.; Lintzeris, N.; Bruno, R.; Peacock, A.; Cama, E.; Ali, R.; Kihas, I.; Hordern, A.; White, N.; Degenhardt, L.
2015A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodonePeacock, A.; Degenhardt, L.; Larance, B.; Cama, E.; Lintzeris, N.; Ali, R.; Bruno, R.
2015Wetlands and human healthFinlayson, C.M.; Horwitz, P.; Weinstein, P.
2015Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocolDegenhardt, L.; Larance, B.; Bruno, R.; Lintzeris, N.; Ali, R.; Farrell, M.
2015Pharmacogenetics of opioid responseSomogyi, A.; Coller, J.; Barratt, D.
2015Early social environment affects the endogenous oxytocin system: a review and future directionsAlves, E.; Fielder, A.; Ghabriel, N.; Sawyer, M.; Buisman-Pijlman, F.
2015Comparison of CYP2D metabolism and hepatotoxicity of the myocardial metabolic agent perhexiline in Sprague-Dawley and Dark Agouti ratsLicari, G.; Somogyi, A.; Milne, R.; Sallustio, B.
2015Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancerSaladores, P.; Muerdter, T.; Eccles, D.; Chowbay, B.; Zgheib, N.; Winter, S.; Ganchev, B.; Eccles, B.; Gerty, S.; Tfayli, A.; Lim, J.; Yap, Y.; Ng, R.; Wong, N.; Dent, R.; Habbal, M.; Schaeffeler, E.; Eichelbaum, M.; Schroth, W.; Schwab, M.; et al.
2015A comparison of patterns of spontaneous adverse drug reaction reporting with St. John's Wort and fluoxetine during the period 2000-2013Hoban, C.; Byard, R.; Musgrave, I.
2015Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomesMartin, J.; Phillips, E.; Thomas, D.; Somogyi, A.
2014Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsiesMd Dom, Z.; Noll, B.; Coller, J.; Somogyi, A.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2014Lethal hepatocellular necrosis associated with herbal polypharmacy in a patient with chronic hepatitis B infectionGilbert, J.; Musgrave, I.; Hoban, C.; Byard, R.
2014Understanding the pharmacology of headacheRolan, P.
20145-HT₁B receptor modulation of the serotonin transporter in vivo: studies using KO miceMontanez, S.; Munn, J.; Owens, W.; Horton, R.; Daws, L.
2014Individual differences underlying susceptibility to addiction: role for the endogenous oxytocin systemBuisman-Pijlman, F.; Sumracki, N.; Gordon, J.; Hull, P.; Carter, C.; Tops, M.
2014Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitroJanefjord, E.; Maag, J.; Harvey, B.; Smid, S.
Collection's Items (Sorted by Issue Date in Descending order): 1 to 20 of 779